Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LAA Closure Devices At The Tipping Point

Executive Summary

Since the FDA approval of Boston Scientific Corp.'s WATCHMAN device in March, the US market for left atrial appendage closure devices has reached a tipping point. With first-to-market advantage in the US, and a four- to five-year lead on the competition in bringing a LAAC device to the US market, BSX is well positioned to gain a strong foothold in this potentially billion dollar plus market; however, several factors will dictate market adoption of these devices in the US, including reimbursement, clinical efficacy, cost and ease of use.

Advertisement

Related Content

Boston Sci's Watchman Gets Positive Medicare Coverage Policy
Who's Next? Emerging LAA Closure Devices
CMS Raises Concerns With New-Technology Payment Candidates
Boston Sci’s Watchman Stroke Device Finally Lands FDA Approval, With Favorable Labeling
Another Advisory Panel For Watchman Yields Another Mixed Result
Third Panel’s The Charm For Watchman? More Delays For Boston Sci’s Stroke Device
Advisory Panel Endorses Boston Scientific’s Watchman Left Atrial Appendage Closure Device
Panel Endorses Atritech Watchman Stroke-Prevention Device In Close Vote

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT035940

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel